172
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Feedback for patients reporting adverse drug reactions; satisfaction and expectations

, PharmD, , PharmD PhD, , MD PhD & , MD PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Leanne J. Kosse, Gerda Weits, Harald E. Vonkeman, Phyllis I. Spuls, Bart J.F. Van Den Bemt, Sander W. Tas, Frank Hoentjen, Mike T. Nurmohamed, Martijn B.A. Van Doorn, Eugène P. Van Puijenbroek & Naomi T. Jessurun. (2020) Immune-mediated inflammatory disease patients’ preferences in adverse drug reaction information regarding biologics. Expert Opinion on Drug Safety 19:8, pages 1049-1054.
Read now
Florence van Hunsel, Linda Härmark & Leàn Rolfes. (2019) Fifteen years of patient reporting –what have we learned and where are we heading to?. Expert Opinion on Drug Safety 18:6, pages 477-484.
Read now

Articles from other publishers (7)

Muhammad Akhtar Abbas Khan, Saima Hamid, Shahzad Ali Khan, Mariyam Sarfraz & Zaheer-Ud-Din Babar. (2022) A Qualitative Study of Stakeholders’ Views on Pharmacovigilance System, Policy, and Coordination in Pakistan. Frontiers in Pharmacology 13.
Crossref
Wiwan Worakunphanich, Sitaporn Youngkong, Wimon Suwankesawong, Claire Anderson & Montarat Thavorncharoensap. (2022) Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries. International Journal of Environmental Research and Public Health 19:8, pages 4447.
Crossref
Kamila Sienkiewicz, Monika Burzyńska, Izabela Rydlewska-Liszkowska, Jacek Sienkiewicz & Ewelina Gaszyńska. (2021) The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process. International Journal of Environmental Research and Public Health 19:1, pages 413.
Crossref
Carrie E. Pierce, Sieta T. de Vries, Stephanie Bodin-Parssinen, Linda Härmark, Phil Tregunno, David J. Lewis, Simon Maskell, Raphael Van Eemeren, Alicia Ptaszynska-Neophytou, Victoria Newbould, Nabarun Dasgupta, Antoni F. Z. Wisniewski, Sara Gama & Peter G. M. Mol. (2019) Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. Drug Safety 42:4, pages 477-489.
Crossref
Gilles Defer, Florian Le Caignec, Sophie Fedrizzi, François Montastruc, Damien Chevanne, Jean-Jacques Parienti & Laure Peyro-Saint-Paul. (2018) Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial. Trials 19:1.
Crossref
Leàn Rolfes, Florence van Hunsel, Laura van der Linden, Katja Taxis & Eugène van Puijenbroek. (2017) The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis. Drug Safety 40:7, pages 607-614.
Crossref
Leàn Rolfes, Florence van Hunsel, Katja Taxis & Eugène van Puijenbroek. (2016) The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. Drug Safety 39:8, pages 769-776.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.